Literature DB >> 2845761

Frequency of extrathoracic metastases from bronchogenic carcinoma in patients with normal-sized hilar and mediastinal lymph nodes on CT.

L Sider1, D Horejs.   

Abstract

The only cure for bronchogenic carcinoma is complete surgical resection; the most common reason for not attempting surgical resection is mediastinal adenopathy. However, we have found that even when the lymph nodes are normal in size, the presence of extrathoracic metastases may preclude successful resection. In a series of 263 patients with pathologically proved non-small cell bronchogenic carcinoma who were seen over a 2-year period, we identified 95 patients in whom a preoperative CT scan showed only a solitary lung mass without evidence of hilar or mediastinal metastases, pleural effusion, or definite chest-wall involvement. The medical records and preoperative imaging studies were evaluated in this group. Twenty-four (25%) of these patients who had potentially resectable masses proved to have extrathoracic metastases; thus they were not candidates for surgery. Occurring in 16 (67%) of these 24 patients, adenocarcinoma was the most common cell type; squamous cell carcinoma was present in five patients (21%), and large cell carcinoma was present in three patients (13%). These findings suggest that extrathoracic metastases from bronchogenic carcinoma may occur without CT evidence of enlarged hilar or mediastinal lymph nodes. Such metastases may preclude successful surgical resection.

Entities:  

Mesh:

Year:  1988        PMID: 2845761     DOI: 10.2214/ajr.151.5.893

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

Review 1.  Staging for M disease.

Authors:  T L Winton
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

2.  Metastasizing lung carcinomas in Hann: Wistar rats.

Authors:  K Kamino; M Kohler; U Mohr
Journal:  Clin Exp Metastasis       Date:  1992-07       Impact factor: 5.150

Review 3.  Staging of bronchogenic carcinoma.

Authors:  S J Herman
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

4.  Utility of 18F-Fluciclovine PET/MRI for Staging Newly Diagnosed High-Risk Prostate Cancer and Evaluating Response to Initial Androgen Deprivation Therapy: A Prospective Single-Arm Pilot Study.

Authors:  Samuel J Galgano; Andrew M McDonald; Soroush Rais-Bahrami; Kristin K Porter; Gagandeep Choudhary; Constantine Burgan; Pradeep Bhambhvani; Jeffrey W Nix; Desiree E Morgan; Yufeng Li; John V Thomas; Jonathan McConathy
Journal:  AJR Am J Roentgenol       Date:  2020-10-14       Impact factor: 6.582

Review 5.  The Utility of Metabolic Imaging by 18F-FDG PET/CT in Lung Cancer: Impact on Diagnosis and Staging.

Authors:  Abbas Yousefi-Koma; Mojgan Panah-Moghaddam; Victor Kalff
Journal:  Tanaffos       Date:  2013

6.  Staging Work-up for Early Lung Cancer: The More the Better?

Authors:  Chang Min Choi; Jae Cheol Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-09-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.